Latest News - Stryker Corporation
Top Corporates Hub
Stryker Corporation
Stryker Expands Peripheral Vascular Reach With Amplitude Deal And Undervalued Shares
22.05.2026 01:15
Stryker (NYSE:SYK) has agreed to acquire Amplitude Vascular Systems. The deal adds hydraulic intravascular lithotripsy technology aimed at treating calcified peripheral arterial disease. The transaction is intended to expand Stryker's peripheral vascular portfolio and support its medical technology focus. Stryker, trading at around $313.5, is using this acquisition to build out its peripheral vascular offerings at a time when calcified peripheral arterial disease remains a difficult area of...
Stryker’s chief accounting officer to retire
21.05.2026 11:06
William Berry Jr. will retire in September, with Corporate Controller Emily Baculik stepping into the role.
Podcast: Supply chains, obesity drugs, and patents dominate Q1 earnings trends
21.05.2026 10:42
The healthcare team covers Q1 results from pharma and medtech companies and provides a wrap-up of the key takeaways.
Is Wall Street Bullish or Bearish on Stryker Corporation Stock?
20.05.2026 06:19
Stryker stock has underperformed the broader market over the past year, but analysts remain highly bullish about its prospects.
Stryker: Investors May Have Overreacted To Q1 Weakness
20.05.2026 02:34
Stryker's integrated 'Smart Hospital' strategy deepens customer lock-in, creating high switching costs and stable long-term demand. See why SYK stock is a Hold.
1 Oversold Stock Set for a Comeback and 2 That Underwhelm
19.05.2026 11:00
The past year hasn't been kind to the stocks featured in this article. Each has tumbled to their lowest points in 12 months, leaving investors to decide whether they're witnessing fire sales or falling knives.
BioStar Capital-Backed Amplitude Vascular Systems’ $835M Acquisition by Stryker Reflects Strength of Michigan’s Medtech Ecosystem
19.05.2026 09:30
CHARLEVOIX, Mich., May 19, 2026--BioStar Capital, a venture capital firm focused on transformative medical technologies, has announced a landmark pre-FDA exit of Amplitude Vascular Systems, Inc. (AVS), a medical technology company that created a next-generation hydraulic intravascular lithotripsy (IVL) platform to treat calcified peripheral arterial disease. Upon acquiring AVS for up to $835 million, Stryker (NYSE:SYK), a global leader in medical technologies, called the deal a milestone in the
Can ISRG's da Vinci 5 Momentum Sustain Procedure and Utilization Gains?
14.05.2026 17:06
ISRG's da Vinci 5 is driving stronger utilization and procedure growth, but can higher throughput and after-hours surgeries sustain momentum?
Here's How Boston Scientific Is Expanding Its Global Growth
14.05.2026 17:05
BSX expands global reach with strong APAC growth, FARAPULSE momentum and new approvals driving gains across Europe and China.
Stryker and Max Smart Hospital, Saket Partner to Advance Surgeon Training and Education in Robotic-Arm Assisted Joint Replacement
13.05.2026 10:49
Stryker, a global leader in medical technologies, and Max Smart Super Speciality Hospital, Saket, a leading healthcare provider in Delhi NCR, announced a strategic collaboration to advance surgeon training, clinical education, and patient care in robotic-arm assisted joint replacement in India.
Tennessee's top export is not whiskey or country music, it's this
13.05.2026 09:07
Whiskey and country music may be synonymous with Tennessee, but they aren't what the state ships the most of.
Stryker closes Amplitude Vascular acquisition
08.05.2026 10:57
With an intravascular lithotripsy platform, Stryker will enter a booming market that has attracted investment from Johnson & Johnson, Boston Scientific and Abbott.
Stryker declares an $0.88 per share quarterly dividend
07.05.2026 08:10
Stryker Corp:* Stryker declares an $0.88 per share quarterly dividend...
Mercury Systems Q3 Earnings Call Highlights
06.05.2026 01:35
Mercury Systems (NASDAQ:MRCY) reported third-quarter fiscal 2026 results that exceeded management’s expectations, driven by stronger-than-planned backlog conversion, record bookings, and year-over-year margin expansion. Chairman and CEO Bill Ballhaus said the quarter reflected “strong demand signals
SYK Q1 Deep Dive: Cyber Incident Disrupts Operations, Management Reiterates Full-Year Outlook
05.05.2026 11:56
Medical technology company Stryker (NYSE:SYK) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 2.6% year on year to $6.02 billion. Its non-GAAP profit of $2.60 per share was 12.9% below analysts’ consensus estimates.
Stryker Corporation (SYK) Q1 2026 Press Conference Call Transcript
01.05.2026 00:41
Stryker Corporation (SYK) Q1 2026 Press Conference Call April 30, 2026 4:30 PM EDTCompany ParticipantsKevin Lobo - Chairman & CEOJason Beach - VP and...
How Investors May Respond To Stryker (SYK) Cyber Disruption As Q1 2026 Earnings Expectations Build
30.04.2026 01:10
Stryker recently faced a cybersecurity disruption and is set to report its first-quarter 2026 results, with analysts watching MedSurg and Neurotechnology performance alongside expected 8% year-on-year revenue growth. Despite the disruption, analysts are emphasizing continued demand for procedures, robotics, and product innovation as they reassess how near-term costs and operational challenges could shape Stryker's earnings path. Next, we’ll examine how expectations for segment growth and...
Wall Street's Insights Into Key Metrics Ahead of Stryker (SYK) Q1 Earnings
27.04.2026 13:15
Besides Wall Street's top-and-bottom-line estimates for Stryker (SYK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2026.
Stryker Cyberattack Puts Spotlight On Resilient Identity And MFA Spending
25.04.2026 01:12
Stryker (NYSE:SYK) recently experienced a significant cyberattack that disrupted elements of its operations. In response, identity management provider Avatier has launched an emergency-ready Multi-Factor Authentication solution. The new offering centers on an air-gapped Identity Challenge Card designed to maintain secure access during system outages. This launch directly addresses vulnerabilities exposed by the incident and targets business continuity during future cyber events. Stryker, a...
Stryker Corp (NYSE:SYK) Passes the Caviar Cruise Quality Screen with a Stellar 40.9% ROIC
24.04.2026 10:10
Stryker Corp passes the "Caviar Cruise" quality stock screener, showing strong revenue and EBIT growth, a 40.9% ROIC, and excellent cash conversion. Discover how this medical technology giant exemplifies durable competitive advantages for long-term investors.